Literature DB >> 28177730

Impaired mitochondria and intracellular calcium transients in the salivary glands of obese rats.

Jitjiroj Ittichaicharoen1, Nattayaporn Apaijai2, Pongpan Tanajak3, Piangkwan Sa-Nguanmoo3, Nipon Chattipakorn3, Siriporn C Chattipakorn1.   

Abstract

Long-term consumption of a high-fat diet (HFD) causes not only obese-insulin resistance, but is also associated with mitochondrial dysfunction in several organs. However, the effect of obese-insulin resistance on salivary glands has not been investigated. We hypothesized that obese-insulin resistance induced by HFD impaired salivary gland function by reducing salivation, increasing inflammation, and fibrosis, as well as impairing mitochondrial function and calcium transient signaling. Male Wistar rats (200-220 g) were fed either a ND or an HFD (n = 8/group) for 16 weeks. At the end of week 16, salivary flow rates, metabolic parameters, and plasma oxidative stress were determined. Rats were then sacrificed and submandibular glands were removed to determine inflammation, fibrosis, apoptosis, mitochondrial function and dynamics, and intracellular calcium transient signaling. Long-term consumption of an HFD caused obese-insulin resistance and increased oxidative stress, fibrosis, inflammation, and apoptosis in the salivary glands. In addition, impaired mitochondrial function, as indicated by increased mitochondrial reactive oxygen species, mitochondrial membrane depolarization, and mitochondrial swelling in salivary glands and impaired intracellular calcium regulation, as indicated by a reduced intracellular calcium transient rising rate, decay rates, and amplitude of salivary acinar cells, were observed in HFD-fed rats. However, salivary flow rate and level of aquaporin 5 protein were not different between both groups. Although HFD consumption did not affect salivation, it caused obese-insulin resistance, leading to pathophysiological alteration of salivary glands, including impaired intracellular calcium transients, increased oxidative stress and inflammation, and salivary mitochondrial dysfunction.

Entities:  

Keywords:  fonction des glandes salivaires; insulin; insuline; metabolic syndrome; mitochondria; mitochondrie; obesity; obésité; salivary gland function; syndrome métabolique

Mesh:

Substances:

Year:  2016        PMID: 28177730     DOI: 10.1139/apnm-2016-0545

Source DB:  PubMed          Journal:  Appl Physiol Nutr Metab        ISSN: 1715-5312            Impact factor:   2.665


  5 in total

1.  Reduced salivary amylase activity in metabolic syndrome patients with obesity could be improved by treatment with a dipeptidyl peptidase IV inhibitor.

Authors:  Jitjiroj Ittichaicharoen; Arintaya Phrommintikul; Nipon Chattipakorn; Siriporn Chattipakorn
Journal:  Clin Oral Investig       Date:  2018-03-08       Impact factor: 3.573

2.  Type 2 diabetes-induced hyposalivation of the submandibular gland through PINK1/Parkin-mediated mitophagy.

Authors:  Ruo-Lan Xiang; Yan Huang; Yan Zhang; Xin Cong; Zhe-Jing Zhang; Li-Ling Wu; Guang-Yan Yu
Journal:  J Cell Physiol       Date:  2019-06-12       Impact factor: 6.384

3.  N-acetylcysteine supplementation did not reverse mitochondrial oxidative stress, apoptosis, and inflammation in the salivary glands of hyperglycemic rats.

Authors:  Zalewska Anna; Kuć Joanna; Zięba Sara; Matczuk Jan; Kostecka-Sochoń Paula; Szarmach Izabela; Ładny Jerzy Robert; Żendzian-Piotrowska Małgorzata; Maciejczyk Mateusz
Journal:  Nutr Diabetes       Date:  2021-11-09       Impact factor: 5.097

4.  High Glucose Reduces the Paracellular Permeability of the Submandibular Gland Epithelium via the MiR-22-3p/Sp1/Claudin Pathway.

Authors:  Yan Huang; Hui-Min Liu; Qian-Ying Mao; Xin Cong; Yan Zhang; Sang-Woo Lee; Kyungpyo Park; Li-Ling Wu; Ruo-Lan Xiang; Guang-Yan Yu
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

Review 5.  Interrelationship between Vitamin D and Calcium in Obesity and Its Comorbid Conditions.

Authors:  Iskandar Azmy Harahap; Jean-François Landrier; Joanna Suliburska
Journal:  Nutrients       Date:  2022-08-03       Impact factor: 6.706

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.